ClinConnect ClinConnect Logo
Search / Trial NCT06987630

Integrated Pulmonary Index Monitoring on the Incidence of Hypoxemia in Elderly Patients With Painless Colonoscopy

Launched by THE FIRST PEOPLE'S HOSPITAL OF LIANYUNGANG · May 15, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Elderly Patients Colonoscopy Propofol

ClinConnect Summary

This clinical trial is studying whether a special monitoring system called the Integrated Pulmonary Index (IPI) can help reduce the risk of low oxygen levels (hypoxemia) during painless colonoscopies in older patients. The trial will compare two groups: one group will have their IPI monitored continuously, while the other group will not use this system. The goal is to see if continuous monitoring can help doctors respond more quickly to any drops in oxygen levels during the procedure.

To participate in this trial, individuals must be at least 65 years old and scheduled for a painless colonoscopy without needing to be intubated (a tube placed in the throat for breathing support). Participants should be mentally alert and able to consent to the study. During the procedure, those in the monitoring group will have their oxygen and other vital signs checked regularly, and the medical team will take specific actions if the IPI indicates a need for extra support. This trial is important because it aims to improve the safety of colonoscopy procedures for elderly patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who were selected for non-intubated painless colonoscopy;
  • Age≥ 65 years;
  • American Society of Anesthesiologists (ASA) grade I\~III;
  • Conscious, no cognitive dysfunction and other mental illnesses;
  • Voluntarily participate in this study and sign the informed consent form
  • Exclusion Criteria:
  • Patients with severe circulatory system diseases, respiratory diseases, and central nervous system diseases;
  • Patients with severe abnormal liver and kidney function;
  • Those who are allergic to any of the drugs used in the study;
  • Participated in other clinical studies within the last 3 months

About The First People's Hospital Of Lianyungang

The First People's Hospital of Lianyungang is a leading healthcare institution dedicated to advancing medical research and clinical excellence. As a prominent clinical trial sponsor, the hospital prioritizes patient-centered care while fostering innovation in medical practices. With a commitment to improving health outcomes, the hospital collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous clinical trials across various therapeutic areas. Their focus on ethical standards, compliance, and scientific integrity ensures that trials not only contribute to the global body of medical knowledge but also enhance the quality of care for the communities they serve.

Locations

Lianyungang, Jiangsu, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported